Beam Therapeutics Inc. (BEAM) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$25.84
Day's range
$27.92

Beam Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 08/13/2026 12.61 M $432.74 M   1.26% 12.21%
FARALLON CAPITAL MANAGEMENT LLC 08/14/2026 10.24 M $351.31 M   1.00% 9.91%
ARK INVESTMENT MANAGEMENT LLC 08/14/2026 10.23 M $351.26 M   -15.65% 9.91%
BLACKROCK, INC. 08/07/2026 9.00 M $308.80 M   6.01% 8.71%
STATE STREET CORP 08/07/2026 5.83 M $199.99 M   2.24% 5.64%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 4.92 M $168.90 M   7.67% 4.77%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 4.60 M $157.85 M   5.07% 4.45%
ARCH VENTURE MANAGEMENT, LLC 08/14/2026 4.54 M $155.77 M   0.00% 4.40%
SUMITOMO MITSUI TRUST GROUP, INC. 07/30/2026 3.46 M $118.58 M   -9.69% 3.35%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 08/13/2026 3.46 M $118.54 M   -9.69% 3.35%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 3.42 M $117.21 M   25.87% 3.31%
KYNAM CAPITAL MANAGEMENT, LP 08/14/2026 2.84 M $97.50 M   -22.85% 2.75%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 2.60 M $89.14 M   7.38% 2.51%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 2.23 M $76.40 M   3.31% 2.16%
MORGAN STANLEY 08/13/2026 1.95 M $66.96 M   200.95% 1.89%
CONTRARIUS GROUP HOLDINGS LTD 08/11/2026 1.61 M $55.41 M   202.66% 1.56%
UBS ASSET MANAGEMENT AMERICAS INC 08/13/2026 1.55 M $53.26 M   -6.16% 1.50%
TWO SIGMA INVESTMENTS, LP 08/14/2026 1.39 M $47.64 M   14.65% 1.34%
CASDIN CAPITAL, LLC 08/14/2026 1.35 M $46.33 M   0.00% 1.31%
GOLDMAN SACHS GROUP INC 08/14/2026 1.31 M $44.96 M   30.26% 1.27%
REDMILE GROUP, LLC 08/14/2026 1.16 M $39.96 M   -5.93% 1.13%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 1.07 M $36.65 M   52.41% 1.03%
DEEP TRACK CAPITAL, LP 08/14/2026 1.00 M $34.32 M   21.84% 0.97%
NORTHERN TRUST CORP 08/13/2026 933.48 K $32.04 M   13.07% 0.90%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 885.90 K $30.40 M   9.58% 0.86%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 885.90 K $30.40 M   100.00% 0.86%
BANK OF AMERICA CORP /DE/ 08/14/2026 720.65 K $24.73 M   33.88% 0.70%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 710.71 K $24.39 M   3.77% 0.69%
UBS GROUP AG 08/13/2026 574.81 K $19.73 M   -30.42% 0.56%
RTW INVESTMENTS, LP 08/14/2026 570.39 K $19.58 M   0.00% 0.55%
JPMORGAN CHASE & CO 08/12/2026 514.77 K $18.14 M   -6.64% 0.50%
MARSHALL WACE, LLP 08/13/2026 478.98 K $16.44 M   243.99% 0.46%
ELMIND CAPITAL, LP 08/14/2026 476.34 K $16.35 M   0.00% 0.46%
IQ EQ FUND MANAGEMENT (IRELAND) LTD 07/31/2026 455.95 K $15.65 M   -6.65% 0.44%
JUPITER ASSET MANAGEMENT LTD 08/10/2026 445.72 K $15.30 M   1,752.53% 0.43%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 445.00 K $15.27 M   -13.35% 0.43%
BANK OF NEW YORK MELLON CORP 08/06/2026 362.80 K $12.45 M   5.32% 0.35%
FORESITE CAPITAL MANAGEMENT VI LLC 08/14/2026 330.00 K $11.33 M   100.00% 0.32%
ALPHABET INC. 08/07/2026 321.60 K $11.04 M   0.00% 0.31%
BAILLIE GIFFORD & CO 08/06/2026 314.23 K $10.78 M   -18.57% 0.30%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 08/14/2026 300.00 K $10.30 M   0.00% 0.29%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 08/13/2026 296.29 K $10.17 M   100.00% 0.29%
PICTET ASSET MANAGEMENT HOLDING SA 07/30/2026 250.80 K $8.76 M   -15.70% 0.24%
CITADEL ADVISORS LLC 08/14/2026 246.20 K $8.45 M   5.94% 0.24%
NUVEEN, LLC 08/11/2026 245.28 K $8.42 M   5.45% 0.24%
AMERICAN CENTURY COMPANIES INC 08/12/2026 204.70 K $7.03 M   21.36% 0.20%
INVESCO LTD. 08/14/2026 194.17 K $6.66 M   -11.72% 0.19%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 194.08 K $6.66 M   -82.11% 0.19%
WELLS FARGO & COMPANY/MN 08/14/2026 189.39 K $6.50 M   43.21% 0.18%
MACKENZIE FINANCIAL CORP 08/13/2026 185.50 K $6.37 M   100.00% 0.18%

Beam Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 361 institutional investors and hedge funds held shares of Beam Therapeutics Inc. The most heavily invested institutionals were:

FMR LLC: 12.61 M

FARALLON CAPITAL MANAGEMENT LLC: 10.24 M

ARK Investment Management LLC: 10.23 M

BlackRock, Inc.: 9 M

STATE STREET CORP: 5.83 M

VANGUARD PORTFOLIO MANAGEMENT LLC: 4.92 M

106.65% of Beam Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 131.56 M shares in the last 24 months. This purchase volume represents approximately $3.63 B in transactions.